What severity of aortic stenosis is indicated by a dimensionless velocity ratio (left ventricular outflow tract velocity-time integral ÷ aortic velocity-time integral) of 0.42?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dimensionless Ratio of 0.42 Represents Mild-to-Moderate Aortic Stenosis

A dimensionless velocity ratio (also called velocity ratio or dimensionless index) of 0.42 indicates mild-to-moderate aortic stenosis, well above the threshold for severe disease. This value suggests the effective aortic valve area is approximately 42% of the patient's normal left ventricular outflow tract area, which is substantially larger than what defines severe stenosis.

Understanding the Dimensionless Index

The dimensionless index is calculated as:

  • LVOT velocity ÷ Aortic valve velocity (or LVOT VTI ÷ AV VTI)

This ratio approaches 1.0 in normal valves, with progressively smaller numbers indicating worsening stenosis 1.

Severity Classification

According to the 2020 ACC/AHA Guidelines and the 2017 EACVI/ASE Focused Update, the critical threshold for severe aortic stenosis is:

  • Dimensionless ratio ≤0.25 = Severe AS 2, 1

This cutoff corresponds to a valve area that is 25% or less of the patient's normal expected valve area and is a validated predictor of symptom onset and adverse outcomes 2.

Your Patient's Value of 0.42

With a ratio of 0.42, this patient has:

  • Nearly twice the dimensionless index of the severe AS threshold
  • An effective valve area approximately 42% of their normal LVOT area
  • No evidence of severe stenosis by this parameter

Clinical Context and Integration

The dimensionless index has several advantages 1:

  • Independent of body size (already normalized to the patient's LVOT)
  • Eliminates measurement errors from LVOT diameter calculation
  • Particularly useful when other AS parameters are discordant

However, do not rely on dimensionless index alone. The primary parameters for AS severity grading remain 2, 1:

  1. Peak aortic jet velocity (severe if ≥4.0 m/s)
  2. Mean pressure gradient (severe if ≥40 mmHg)
  3. Aortic valve area (severe if <1.0 cm²)

Important Caveats

When dimensionless index appears discordant with other parameters:

  • Verify LVOT velocity measurement quality (should be laminar flow without spectral dispersion) 1
  • Confirm aortic jet velocity was obtained from multiple windows using dedicated continuous-wave Doppler 1
  • Consider measurement errors in LVOT diameter if calculated AVA seems inconsistent 3
  • Evaluate for low-flow states (stroke volume index <35 mL/m²) that may affect gradient-based parameters 1

In low-gradient AS with preserved ejection fraction, a dimensionless index <0.25 has proven particularly valuable for risk stratification, identifying patients at higher mortality risk who benefit from intervention 4, 5. Your patient's value of 0.42 places them well outside this high-risk category.

Prognostic Implications

Research demonstrates that dimensionless index provides independent prognostic information 6, 7:

  • Values <0.25 associate with significantly increased mortality and cardiovascular events
  • The parameter performs especially well in patients with reduced ejection fraction or low-flow states 7, 5
  • A value of 0.42 suggests favorable hemodynamics from a prognostic standpoint

Bottom line: This dimensionless ratio of 0.42 does not meet criteria for severe aortic stenosis and likely represents mild-to-moderate disease, assuming other echocardiographic parameters are concordant.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.